In the present study, we attempt to demonstrate that OV/PD-1 antibody combination might be necessary for the anti-tumour function of infiltrating T cells through restricting tumour resistance induced by oncolytic herpes simplex virus-1 (oHSV-1). The gene discussed is PDCD1; the disease is neoplasm.